Skip to content

Takeda

Takeda
Professor Emiliangelo Ratti, head of Neuroscience Therapeutic Area for the Takeda Corporation worldwide.

Cardiff University has formed a partnership with Takeda Pharmaceutical Company Limited (Takeda) for a drug discovery collaboration to identify new approaches for treating schizophrenia and other psychiatric disorders.

The collaboration will combine the University's large scale genomic data and world-class expertise in psychiatric genetics, genomics, clinical and basic neuroscience with Takeda’s extensive drug discovery and clinical development capabilities.

The collaboration will allow Takeda access to world-leading biological psychiatry research and the related infrastructure across the University, including the

Enquiries

For more information regarding the Takeda partnership, please contact:

Professor Lawrence Wilkinson

Professor Lawrence Wilkinson

Scientific Director, Neuroscience and Mental Health Research Institute.

Email:
wilkinsonl@cardiff.ac.uk
Telephone:
+44(0) 29 2068 8461